ST7612AA1
ST7612AA1 is a novel potent and oral HDCA inhibitor that acts as an HIV-1 latency reactivator. ST7612AA1 showed significant antitumor activity at low concentrations in vitro and in vivo. ST7612AA1 has potential anticancer activity and can be used to study malaria.
Product Specifications
CAS Number
1428535-92-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
405.51
Molecular Formula
C20H27N3O4S
Notes
Research use only, not for human use.
Receptor
HIV Protease
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog